Chesnara Plc: Fourth acquisition in two years
12 November 2026
Septerna, Inc. (NASDAQ: SEPN) has recently captured investor attention with its impressive potential upside of 80.63%, as reflected in the latest analyst ratings. Operating within the..
Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector, specifically within the medical devices industry, presents a compelling yet challenging opportunity for investors...
Enhabit, Inc. (NASDAQ: EHAB) stands at the forefront of the healthcare sector, specifically within the medical care facilities industry, by delivering essential home health and hospice..
Precigen, Inc. (NASDAQ: PGEN) stands as a compelling opportunity within the biotechnology sector, offering investors a unique blend of innovation and high potential upside. With a..
AngioDynamics, Inc. (NASDAQ: ANGO), a noteworthy player in the healthcare sector, stands out with a compelling growth potential that could catch the eye of savvy investors...
Celcuity Inc. (NASDAQ: CELC) has emerged as a notable player in the biotechnology sector, capturing investor interest with its innovative approach to developing targeted cancer therapies...
Oruka Therapeutics, Inc. (NYSE: ORKA), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline of monoclonal antibody therapeutics aimed at tackling..
Altimmune, Inc. (NASDAQ: ALT), a promising player in the biotechnology sector, is capturing the attention of investors with its significant potential upside and compelling analyst ratings...
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) stands at the forefront of the biotechnology industry with its pioneering focus on developing adeno-associated virus-based gene therapies targeting severe..
Bioventus Inc. (NASDAQ: BVS) stands out in the healthcare sector, particularly within the medical devices industry, thanks to its innovative approach to pain relief and musculoskeletal..
Investors with an eye on the biotechnology sector may find Dianthus Therapeutics, Inc. (NASDAQ: DNTH) particularly intriguing. This New York-based clinical-stage biotech company is making notable..
Kamada Ltd. (NASDAQ: KMDA), an Israeli healthcare company specializing in plasma-derived protein therapeutics, boasts a robust market presence and compelling investment potential. Operating within the Drug..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a trailblazer in the biotechnology sector, is poised on the cusp of significant growth with a potential upside of 86.89%. As..
Fortrea Holdings Inc. (NASDAQ: FTRE) stands as a notable player in the biotechnology industry, offering a comprehensive range of research and development solutions to pharmaceutical and..
Autolus Therapeutics plc (NASDAQ: AUTL) is capturing the attention of the biotech investment community with its ambitious pipeline of T cell therapies and compelling upside potential...
Treace Medical Concepts, Inc. (NASDAQ: TMCI), a healthcare company specializing in innovative medical devices, has captured the attention of investors with its potential upside of 193.89%...
Ardelyx, Inc. (NASDAQ: ARDX) is making waves in the biotechnology sector with its innovative approach to addressing unmet medical needs. With a market capitalization of $1.35..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has captured the attention of investors in the biotechnology sector due to its promising clinical-stage developments and significant potential for stock..
Inventiva S.A. (NYSE: IVA), a French clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline focused on treating metabolic dysfunction-associated steatohepatitis..
InMode Ltd. (NASDAQ: INMD), a key player in the healthcare sector, is making waves in the medical devices industry with its innovative range of minimally and..
